X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS AJANTA PHARMA DR. DATSONS LABS/
AJANTA PHARMA
 
P/E (TTM) x -10.9 19.8 - View Chart
P/BV x 0.2 4.5 3.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   AJANTA PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
AJANTA PHARMA
Mar-18
DR. DATSONS LABS/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1261,818 6.9%   
Low Rs311,106 2.8%   
Sales per share (Unadj.) Rs133.0239.5 55.5%  
Earnings per share (Unadj.) Rs0.252.8 0.3%  
Cash flow per share (Unadj.) Rs6.659.5 11.1%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.8230.0 56.0%  
Shares outstanding (eoy) m31.6688.77 35.7%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.66.1 9.6%   
Avg P/E ratio x516.127.7 1,863.7%  
P/CF ratio (eoy) x11.824.6 48.2%  
Price / Book Value ratio x0.66.4 9.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,477129,782 1.9%   
No. of employees `000NA6.8 0.0%   
Total wages/salary Rs m563,765 1.5%   
Avg. sales/employee Rs ThNM3,128.4-  
Avg. wages/employee Rs ThNM554.0-  
Avg. net profit/employee Rs ThNM689.7-  
INCOME DATA
Net Sales Rs m4,21121,258 19.8%  
Other income Rs m79242 32.6%   
Total revenues Rs m4,28921,499 20.0%   
Gross profit Rs m5696,584 8.6%  
Depreciation Rs m204596 34.3%   
Interest Rs m4304 10,492.7%   
Profit before tax Rs m136,226 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m61,539 0.4%   
Profit after tax Rs m54,686 0.1%  
Gross profit margin %13.531.0 43.6%  
Effective tax rate %48.024.7 194.3%   
Net profit margin %0.122.0 0.5%  
BALANCE SHEET DATA
Current assets Rs m6,85212,236 56.0%   
Current liabilities Rs m6,7113,461 193.9%   
Net working cap to sales %3.341.3 8.1%  
Current ratio x1.03.5 28.9%  
Inventory Days Days16160 267.1%  
Debtors Days Days31884 377.0%  
Net fixed assets Rs m3,67311,140 33.0%   
Share capital Rs m317177 179.0%   
"Free" reserves Rs m3,76120,237 18.6%   
Net worth Rs m4,07820,414 20.0%   
Long term debt Rs m1,67110 16,542.6%   
Total assets Rs m12,63324,486 51.6%  
Interest coverage x1.01,519.4 0.1%   
Debt to equity ratio x0.40 82,819.2%  
Sales to assets ratio x0.30.9 38.4%   
Return on assets %3.419.2 18.0%  
Return on equity %0.123.0 0.5%  
Return on capital %7.730.5 25.2%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96411,667 8.3%   
Fx outflow Rs m6071,616 37.6%   
Net fx Rs m35710,052 3.6%   
CASH FLOW
From Operations Rs m1,3452,854 47.1%  
From Investments Rs m-2,256-2,604 86.6%  
From Financial Activity Rs m-1,200-2 59,990.0%  
Net Cashflow Rs m-2,111248 -850.7%  

Share Holding

Indian Promoters % 4.5 73.8 6.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 1.6 -  
FIIs % 1.4 7.6 17.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 17.0 553.5%  
Shareholders   20,807 20,968 99.2%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   ASTRAZENECA PHARMA  PANACEA BIOTECH  WOCKHARDT LTD.  GSK PHARMA  PLETHICO PHARMA  

Compare DR. DATSONS LABS With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Rising Oil Prices; RBI Minutes and Top Stocks in Action Today(Pre-Open)

Indian share markets surged on Wednesday, snapping a two-day losing streak led by gains Reliance Industries and bank stocks.

Related Views on News

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - GSK PHARMA COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS